Precision Oncology Initiative

Forming the Future of Cancer Care

Thanks to recent medical advances, precision oncology has developed into the fast-approaching future of optimized cancer care - and HOPA wants to ensure oncology pharmacists and their expertise are there for patients in that future.

To do so, HOPA introduces the Precision Oncology Initiative, a multi-year and multi-phase collaborative effort to advance the integration of oncology pharmacists into precision medicine, driving innovation, improving the quality of cancer care, and delivering long-term value across the healthcare system.

The Precision Oncology Initiative features five key phases:

Stakeholder Interviews

HOPA will conduct a series of information-gathering interviews and facilitated discussions with key stakeholders - including industry partners, healthcare decision-makers, clinicians, and administrators - to gain diverse insights into the most pressing needs, challenges, and opportunities in precision oncology.

Strategic partners will play a vital role in shaping this dialogue, helping to identify gaps, share expertise, and inform collaborative solutions that can accelerate the integration of oncology pharmacists in precision medicine.

Educational Programming

To support the evolving needs of the oncology workforce, HOPA will launch an educational program designed to build foundational knowledge in precision oncology for oncology pharmacists at all career stages. This programming will cover core concepts such as biomarker testing, pharmacogenomics, and the role of precision medicine across the cancer care continuum.

A key element of this phase is HOPA's partnership with ASCO's One-Day Quality Training Program (QTP), which equips pharmacists with the basics of quality improvement to drive meaningful change in oncology care.

HOPA/ASCO 6-Month QTP

In collaboration with ASCO's Quality Training Program (QTP), HOPA will support 10 multidisciplinary, pharmacist-led teams from cancer care sites across the country in completing quality improvement (QI) projects all focused on precision medicine in oncology. Each team will be paired with an ASCO QTP coach and guided through every stage of the QI process - from project design to implementation and evaluation.

Throughout the initiative, teams will share progress updates, including key learnings, successes, and challenges - creating opportunities for shared insights and identifying scalable best practices.

The application window is now open! Click here to learn more!

Precision Oncology Summit

HOPA will host a summit with oncology pharmacists, industry partners, collaborative organizations, and healthcare decision-makers to address key barriers to precision oncology implementation and access.

The summit will also feature insights from the HOPA/ASCO QTP teams, sharing outcomes and best practices from their quality improvement projects. These conversations will shape HOPA's strategy to close identified gaps and guide the development of real-world tools and resources for clinical practice.

Professional Tools and Resources

Building on insights from earlier phases, HOPA will collaborate with strategic partners to develop practical tools and resources that support the integration of precision oncology into pharmacists' daily practice.

HOPA will develop materials such as guidance documents, decision-support tools, and educational content aimed at improving treatment selection, care coordination, and patient outcomes. These resources will be designed for broad adoption across the healthcare team, helping to standardize and scale precision oncology practices nationwide.

Sponsors

If you are interested in partnering on this initiative or would like to learn more, please contact HOPA Director of Strategic Partnership Nicole Watts at nwatts@hoparx.org.